Diabetic macular edema: current and emerging therapies

Diabetic macular edema is a leading cause of vision impairment among people within the working- age population. This review discusses the pathogenesis of diabetic macular edema and the treatment options currently available for the treatment of diabetic macular edema, including for focal/grid photoco...

Full description

Saved in:
Bibliographic Details
Published in:Middle East African journal of ophthalmology 2012-01, Vol.19 (1), p.4-12
Main Authors: Wenick, Adam S, Bressler, Neil M
Format: Article
Language:English
Subjects:
Apoptosis
Blood pressure
Care and treatment
Clinical medicine
Clinical trials
Corticosteroids
Diabetes
Diabetic retinopathy
Diabetics
Diagnosis
Diseases
Eye diseases
Health aspects
Kinases
Lasers
Pathogenesis
Retina
Review
Risk factors
Vascular endothelial growth factor
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diabetic macular edema is a leading cause of vision impairment among people within the working- age population. This review discusses the pathogenesis of diabetic macular edema and the treatment options currently available for the treatment of diabetic macular edema, including for focal/grid photocoagulation, intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents. The biologic rationale for novel therapeutic agents, many of which are currently being evaluated in clinical trials, also is reviewed.
ISSN:0974-9233
0975-1599
0975-1599
0974-9233
DOI:10.4103/0974-9233.92110